Affinity Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
LMFP
AAMU
CRM
SP
ORIO
CNB
Affinity Capital Advisors's MRK Position: Q2 2026 in Review
Affinity Capital Advisors increased its Merck (MRK) stake by 2.2% in Q2 2026, buying an estimated $12.5K and bringing the position to 4,984 shares worth $632K. The position accounts for 0.08% of the portfolio, ranked #98.
Affinity Capital Advisors first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. The position peaked at $706K in Q4 2019. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Affinity Capital Advisors held 4,984 shares of Merck worth $632K as of Q2 2026.
- Affinity Capital Advisors bought 107 Merck shares in Q2 2026, an estimated $12.5K.
- Merck made up 0.08% of Affinity Capital Advisors's portfolio in Q2 2026, its #98 holding.
- Affinity Capital Advisors first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
- Affinity Capital Advisors's Merck position peaked at $706K in Q4 2019.
- 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Affinity Capital Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.